Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | C162W |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | VHL C162W lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). C162W is predicted to confer a loss of function to the Vhl protein, as indicated by failure to induce protein ubiquitination in culture (PMID: 17350623). |
Associated Drug Resistance | |
Category Variants Paths |
VHL mutant VHL inact mut VHL C162W |
Transcript | NM_000551.4 |
gDNA | chr3:g.10149809C>G |
cDNA | c.486C>G |
Protein | p.C162W |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000551 | chr3:g.10149809C>G | c.486C>G | p.C162W | RefSeq | GRCh38/hg38 |
NM_000551.3 | chr3:g.10149809C>G | c.486C>G | p.C162W | RefSeq | GRCh38/hg38 |
NM_000551.4 | chr3:g.10149809C>G | c.486C>G | p.C162W | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|